Nanomedical Diagnostics CTO Brett Goldsmith to Speak at David Myszka ’s...

Dr. Goldsmith will share experiments showcasing characterization of MYC oncoprotein, Zika virus, G-protein-coupled receptors, and aptamers with Agile R100, a versatile Field Effect Biosensing system.(PRWeb September 18, 2018)Read the full story at https://www.prweb.com/releases/nanomedical_diagnostics_cto_brett_goldsmith_to_speak_at_david_myszkas_sensorcon_2018_conference/prweb15769163.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news